Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: idarucizumab | Statement: [dabigatran, hasReversalAgent, idarucizumab]

Target entity: idarucizumab
Context triple: [dabigatran, hasReversalAgent, idarucizumab]

• A. faricimab
  Faricimab is a bispecific monoclonal antibody used to treat neovascular eye diseases such as wet age-related macular degeneration and diabetic macular edema by targeting both VEGF-A and Ang-2 pathways.
• B. Taltz
  Taltz is a prescription biologic medication (ixekizumab) used to treat moderate to severe plaque psoriasis and certain types of arthritis by targeting the inflammatory protein IL-17A.
• C. avelumab
  Avelumab is a human monoclonal antibody immunotherapy drug used to treat certain cancers by blocking the PD-L1 immune checkpoint pathway.
• D. aflibercept
  Aflibercept is an anti-VEGF biologic drug used primarily to treat neovascular (wet) age-related macular degeneration and other retinal vascular diseases.
• E. Dupixent
  Dupixent is a prescription biologic medication (dupilumab) used to treat moderate-to-severe inflammatory conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: idarucizumab
Triple: [dabigatran, hasReversalAgent, idarucizumab]

Idarucizumab is a monoclonal antibody fragment used as a specific antidote to rapidly reverse the anticoagulant effects of dabigatran in cases of emergency or uncontrolled bleeding.

Target entity: idarucizumab
Target entity description: Idarucizumab is a monoclonal antibody fragment used as a specific antidote to rapidly reverse the anticoagulant effects of dabigatran in cases of emergency or uncontrolled bleeding.

• A. faricimab
  Faricimab is a bispecific monoclonal antibody used to treat neovascular eye diseases such as wet age-related macular degeneration and diabetic macular edema by targeting both VEGF-A and Ang-2 pathways.
• B. Taltz
  Taltz is a prescription biologic medication (ixekizumab) used to treat moderate to severe plaque psoriasis and certain types of arthritis by targeting the inflammatory protein IL-17A.
• C. avelumab
  Avelumab is a human monoclonal antibody immunotherapy drug used to treat certain cancers by blocking the PD-L1 immune checkpoint pathway.
• D. aflibercept
  Aflibercept is an anti-VEGF biologic drug used primarily to treat neovascular (wet) age-related macular degeneration and other retinal vascular diseases.
• E. Dupixent
  Dupixent is a prescription biologic medication (dupilumab) used to treat moderate-to-severe inflammatory conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps.
• F. None of above. chosen

Target predicate: hasReversalAgent
Context triple: [dabigatran, hasReversalAgent, idarucizumab]

• A. hasAgent
  Indicates that an action or event is carried out or initiated by a particular agent.
• B. isRemittanceDependent
  Indicates that one party’s financial situation or obligations rely significantly on receiving remittance payments from another party.
• C. isBillingAuthorityFor
  Indicates that one entity has the official responsibility and authority to issue bills or invoices to another entity or on its behalf.
• D. hasIssuerStockTransferAgent
  Indicates that an entity has a designated stock transfer agent responsible for managing the issuance and transfer of its securities.
• E. hasReverse
  Indicates that one entity serves as the inverse or opposite counterpart of another entity in a given relationship or operation.
• F. None of above. chosen